Seagen
SGEN
#552
Rank
C$58.60 B
Marketcap
C$310.65
Share price
-0.07%
Change (1 day)
59.64%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -C$1.07 Billion

According to Seagen 's latest financial reports the company's current earnings are C$2.30 Billion. In 2022 the company made an earning of -C$0.84 Billion, an increase over its 2021 earnings that were of -C$0.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$1.07 Billion27.95%
2022 -C$0.84 Billion-10.13%
2021 -C$0.93 Billion-214.28%
2020 C$0.81 B-370.63%
2019 -C$0.3 Billion-15.17%
2018 -C$0.36 Billion32.79%
2017 -C$0.27 Billion37.19%
2016 -C$0.2 Billion18%
2015 -C$0.17 Billion56.34%
2014 -C$0.11 Billion23.07%
2013 -C$85.38 Million
2011 -C$0.2 Billion111.72%
2010 -C$92.62 Million-19.63%
2009 -C$0.12 Billion-7.55%
2008 -C$0.13 Billion64.95%
2007 -C$75.58 Million38.4%
2006 -C$54.61 Million25.36%
2005 -C$43.56 Million-14.86%
2004 -C$51.16 Million61.92%
2003 -C$31.6 Million-7.67%
2002 -C$34.22 Million6.76%
2001 -C$32.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.09 B-1,599.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.25 B-309.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.58 B-340.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.90 B-1,116.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.66 B-1,279.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$84.04 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-C$85.26 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.35 Billion-67.59%๐Ÿ‡บ๐Ÿ‡ธ USA